Finland Health Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland
Conditions:   Metastatic Castration Sensitive Prostate Cancer (mCSPC);   Metastatic Castration Resistant Prostate Cancer (mCRPC) Interventions:   Drug: abiraterone;   Drug: enzalutamide;   Drug: docetaxel;   Drug: apalutamide;   Drug: cabazitaxel;   Drug: Radium-223;   Drug: Lutetium-177;   Drug: degarelix;   Drug: goserelin;   Drug: leuprorelin;   Drug: triptorelin Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2023 Category: Research Source Type: clinical trials